Celecoxib Capsules(塞来昔布胶囊)

Companies, stages and changes, with each record available on this page.

No changes recorded by this site in the last 90 days
Complete CDE snapshot: 2026/11/10 07:27

Current coverage may be incomplete

Complete CDE snapshot: 2026/11/10 07:27
Matching scope: Same generic name; dosage forms and combinations kept separate
Coverage: Source dates and limits ↓

Which companies are listed, and at what stages?

Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.

Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.

Catalogue holders27View records ↓ Under-review filings5View records ↓ This year’s generic filers2View records ↓ NHSA approval numbers36View records ↓ API companies with A status38View records ↓

Chemical-drug catalogue

Loaded records: 27 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 25 in the new chemical-registration-classification generic category. Category counts may overlap.

Marketing authorization holder	Manufacturer	Approval number	Approved	Strength / specification	Catalogue category (source text)	View source
江西施美药业股份有限公司	江西施美药业股份有限公司	国药准字H20256059	2025/11/25	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
晖致制药（大连）有限公司	晖致制药（大连）有限公司	国药准字H20254652	2025/06/24	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
宜昌人福药业有限责任公司	宜昌人福药业有限责任公司	国药准字H20249827	2024/12/25	0.2g	Not stated by source	CDE
常州制药厂有限公司	常州制药厂有限公司	国药准字H20244510	2024/07/30	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
北京世桥生物制药有限公司	北京世桥生物制药有限公司	国药准字H20243917	2024/06/04	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
湖南诺纳医药科技有限公司	湖南九典制药股份有限公司	国药准字H20243276	2024/02/23	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
中山可可康制药有限公司	中山可可康制药有限公司	国药准字H20243287	2024/02/23	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
福州闽海药业有限公司	福州闽海药业有限公司	国药准字H20234697	2023/12/26	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
四川新斯顿制药股份有限公司	四川新斯顿制药股份有限公司	国药准字H20233911	2023/07/06	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
以岭万洲国际制药有限公司	以岭万洲国际制药有限公司	国药准字H20233445	2023/04/11	0.1g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
四川梓橦宫药业股份有限公司	四川梓橦宫药业股份有限公司	国药准字H20233449	2023/04/11	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
以岭万洲国际制药有限公司	以岭万洲国际制药有限公司	国药准字H20233446	2023/04/11	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
浙江亚太药业股份有限公司	浙江亚太药业股份有限公司	国药准字H20223814	2022/11/08	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
北京亚宝生物药业有限公司	北京亚宝生物药业有限公司	国药准字H20223018	2022/01/18	0.1g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
北京亚宝生物药业有限公司	北京亚宝生物药业有限公司	国药准字H20223019	2022/01/18	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
福建海西新药创制有限公司	南京白敬宇制药有限责任公司	国药准字H20213779	2021/10/11	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
北大医药股份有限公司	北大医药股份有限公司	国药准字H20213717	2021/09/13	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
扬子江药业集团北京海燕药业有限公司	扬子江药业集团北京海燕药业有限公司	国药准字H20213586	2021/07/20	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
四川科伦药业股份有限公司	四川科伦药业股份有限公司	国药准字H20213383	2021/05/19	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
先声药业有限公司	先声药业有限公司	国药准字H20213058	2021/01/27	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
北京福元医药股份有限公司	北京福元医药股份有限公司	国药准字H20213033	2021/01/19	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
天津金耀药业有限公司	天津金耀药业有限公司	国药准字H20203706	2020/12/25	0.1g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
天津金耀药业有限公司	天津金耀药业有限公司	国药准字H20203707	2020/12/25	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
齐鲁制药（海南）有限公司	齐鲁制药（海南）有限公司	国药准字H20203490	2020/09/14	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
齐鲁制药（海南）有限公司	齐鲁制药（海南）有限公司	国药准字H20203489	2020/09/14	0.1g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
四川国为制药有限公司	四川国为制药有限公司	国药准字H20203356	2020/07/29	0.1g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
四川国为制药有限公司	四川国为制药有限公司	国药准字H20203357	2020/07/29	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
青岛百洋制药有限公司	青岛百洋制药有限公司	国药准字H20203325	2020/07/21	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
青岛百洋制药有限公司	青岛百洋制药有限公司	国药准字H20203324	2020/07/21	0.1g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
石药集团欧意药业有限公司	石药集团欧意药业有限公司	国药准字H20203297	2020/07/08	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
石药集团欧意药业有限公司	石药集团欧意药业有限公司	国药准字H20203296	2020/07/08	0.1g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
—	江苏正大清江制药有限公司	国药准字H20193414	2019/12/26	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
江苏恒瑞医药股份有限公司	江苏恒瑞医药股份有限公司	国药准字H20193349	2019/11/28	0.2g	Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药)	CDE
G.D.Searle LLC	Pfizer Pharmaceuticals LLC	H20140107;H20140106	2000/08/04	0.2g	Imported originator drug (进口原研药品)	CDE

Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.

NHSA drug codes

Loaded records: 36 distinct approval numbers and 30 companies.

Company / applicant	Approval number	Strength / specification	NHSA class	NHSA drug code	View source
北京世桥生物制药有限公司	国药准字H20243917	0.2g	Category B (乙)	XM01AHS002E001010100123	NHSA
北京福元医药股份有限公司	国药准字H20213033	0.2g	Category B (乙)	XM01AHS002E001010100177	NHSA
扬子江药业集团北京海燕药业有限公司	国药准字H20213586	0.2g	Category B (乙)	XM01AHS002E001010100237	NHSA
中山可可康制药有限公司	国药准字H20243287	0.2g	Category B (乙)	XM01AHS002E001010100361	NHSA
津药和平(天津)制药有限公司	国药准字H20203707	0.2g	Category B (乙)	XM01AHS002E001010100952	NHSA
常州制药厂有限公司	国药准字H20244510	0.2g	Category B (乙)	XM01AHS002E001010101397	NHSA
江苏恒瑞医药股份有限公司	国药准字H20193349	0.2g	Category B (乙)	XM01AHS002E001010101445	NHSA
江苏正大清江制药有限公司	国药准字H20193414	0.2g	Category B (乙)	XM01AHS002E001010101522	NHSA
福建海西新药创制股份有限公司	国药准字H20213779	0.2g	Category B (乙)	XM01AHS002E001010101554	NHSA
宜昌人福药业有限责任公司	国药准字H20249827	0.2g	Category B (乙)	XM01AHS002E001010102000	NHSA
四川科伦药业股份有限公司	国药准字H20213383	0.2g	Category B (乙)	XM01AHS002E001010102180	NHSA
四川依科制药有限公司	国药准字H20264321	0.2g	Category B (乙)	XM01AHS002E001010102251	NHSA
四川新斯顿制药股份有限公司	国药准字H20233911	0.2g	Category B (乙)	XM01AHS002E001010102273	NHSA
四川梓橦宫药业股份有限公司	国药准字H20233449	0.2g	Category B (乙)	XM01AHS002E001010102300	NHSA
石药集团欧意药业有限公司	国药准字H20203296	0.1g	Category B (乙)	XM01AHS002E001010102770	NHSA
青岛百洋制药有限公司	国药准字H20203324	0.1g	Category B (乙)	XM01AHS002E001010104023	NHSA
浙江亚太药业股份有限公司	国药准字H20223814	0.2g	Category B (乙)	XM01AHS002E001010104744	NHSA
福州闽海药业有限公司	国药准字H20234697	0.2g	Category B (乙)	XM01AHS002E001010104833	NHSA
江西施美药业股份有限公司	国药准字H20256059	0.2g	Category B (乙)	XM01AHS002E001010105356	NHSA
齐鲁制药(海南)有限公司	国药准字H20203489	0.1g	Category B (乙)	XM01AHS002E001010105847	NHSA
先声药业有限公司	国药准字H20213058	0.2g	Category B (乙)	XM01AHS002E001010105849	NHSA
北京亚宝生物药业有限公司	国药准字H20223018	0.1g	Category B (乙)	XM01AHS002E001010109542	NHSA
北大医药股份有限公司	国药准字H20213717	0.2g	Category B (乙)	XM01AHS002E001010109586	NHSA
G.D.Searle LLC	国药准字J20140072	0.2g	Category B (乙)	XM01AHS002E001010178724	NHSA
大桐制药(中国)有限责任公司	国药准字H20255451	0.2g	Category B (乙)	XM01AHS002E001010180685	NHSA
四川国为制药有限公司	国药准字H20203356	0.1g	Category B (乙)	XM01AHS002E001010180937	NHSA
以岭万洲国际制药有限公司	国药准字H20233445	0.1g	Category B (乙)	XM01AHS002E001010181048	NHSA
湖南九典诺纳医药科技有限公司	国药准字H20243276	0.2g	Category B (乙)	XM01AHS002E001010184319	NHSA
晖致制药(大连)有限公司	国药准字H20254652	0.2g	Category B (乙)	XM01AHS002E001010185438	NHSA
北京世桥生物制药有限公司	国药准字H20243917	0.2g	Category B (乙)	XM01AHS002E001010200123	NHSA
北京福元医药股份有限公司	国药准字H20213033	0.2g	Category B (乙)	XM01AHS002E001010200177	NHSA
中山可可康制药有限公司	国药准字H20243287	0.2g	Category B (乙)	XM01AHS002E001010200361	NHSA
津药和平(天津)制药有限公司	国药准字H20203707	0.2g	Category B (乙)	XM01AHS002E001010200952	NHSA
常州制药厂有限公司	国药准字H20244510	0.2g	Category B (乙)	XM01AHS002E001010201397	NHSA
江苏正大清江制药有限公司	国药准字H20193414	0.2g	Category B (乙)	XM01AHS002E001010201522	NHSA
福建海西新药创制股份有限公司	国药准字H20213779	0.2g	Category B (乙)	XM01AHS002E001010201554	NHSA
四川科伦药业股份有限公司	国药准字H20213383	0.2g	Category B (乙)	XM01AHS002E001010202180	NHSA
四川依科制药有限公司	国药准字H20264321	0.2g	Category B (乙)	XM01AHS002E001010202251	NHSA
四川新斯顿制药股份有限公司	国药准字H20233911	0.2g	Category B (乙)	XM01AHS002E001010202273	NHSA
四川梓橦宫药业股份有限公司	国药准字H20233449	0.2g	Category B (乙)	XM01AHS002E001010202300	NHSA
石药集团欧意药业有限公司	国药准字H20203296	0.1g	Category B (乙)	XM01AHS002E001010202770	NHSA
青岛百洋制药有限公司	国药准字H20203324	0.1g	Category B (乙)	XM01AHS002E001010204023	NHSA
浙江亚太药业股份有限公司	国药准字H20223814	0.2g	Category B (乙)	XM01AHS002E001010204744	NHSA
福州闽海药业有限公司	国药准字H20234697	0.2g	Category B (乙)	XM01AHS002E001010204833	NHSA
江西施美药业股份有限公司	国药准字H20256059	0.2g	Category B (乙)	XM01AHS002E001010205356	NHSA
齐鲁制药(海南)有限公司	国药准字H20203489	0.1g	Category B (乙)	XM01AHS002E001010205847	NHSA
先声药业有限公司	国药准字H20213058	0.2g	Category B (乙)	XM01AHS002E001010205849	NHSA
北大医药股份有限公司	国药准字H20213717	0.2g	Category B (乙)	XM01AHS002E001010209586	NHSA
G.D.Searle LLC	国药准字J20140072	0.2g	Category B (乙)	XM01AHS002E001010278724	NHSA
大桐制药(中国)有限责任公司	国药准字H20255451	0.2g	Category B (乙)	XM01AHS002E001010280685	NHSA
以岭万洲国际制药有限公司	国药准字H20233445	0.1g	Category B (乙)	XM01AHS002E001010281048	NHSA
湖南九典诺纳医药科技有限公司	国药准字H20243276	0.2g	Category B (乙)	XM01AHS002E001010284319	NHSA
晖致制药(大连)有限公司	国药准字H20254652	0.2g	Category B (乙)	XM01AHS002E001010285438	NHSA
北京世桥生物制药有限公司	国药准字H20243917	0.2g	Category B (乙)	XM01AHS002E001010300123	NHSA
北京福元医药股份有限公司	国药准字H20213033	0.2g	Category B (乙)	XM01AHS002E001010300177	NHSA
中山可可康制药有限公司	国药准字H20243287	0.2g	Category B (乙)	XM01AHS002E001010300361	NHSA
常州制药厂有限公司	国药准字H20244510	0.2g	Category B (乙)	XM01AHS002E001010301397	NHSA
江苏正大清江制药有限公司	国药准字H20193414	0.2g	Category B (乙)	XM01AHS002E001010301522	NHSA
福建海西新药创制股份有限公司	国药准字H20213779	0.2g	Category B (乙)	XM01AHS002E001010301554	NHSA
四川依科制药有限公司	国药准字H20264321	0.2g	Category B (乙)	XM01AHS002E001010302251	NHSA
四川新斯顿制药股份有限公司	国药准字H20233911	0.2g	Category B (乙)	XM01AHS002E001010302273	NHSA
四川梓橦宫药业股份有限公司	国药准字H20233449	0.2g	Category B (乙)	XM01AHS002E001010302300	NHSA
青岛百洋制药有限公司	国药准字H20203324	0.1g	Category B (乙)	XM01AHS002E001010304023	NHSA
浙江亚太药业股份有限公司	国药准字H20223814	0.2g	Category B (乙)	XM01AHS002E001010304744	NHSA
福州闽海药业有限公司	国药准字H20234697	0.2g	Category B (乙)	XM01AHS002E001010304833	NHSA
先声药业有限公司	国药准字H20213058	0.2g	Category B (乙)	XM01AHS002E001010305849	NHSA
北大医药股份有限公司	国药准字H20213717	0.2g	Category B (乙)	XM01AHS002E001010309586	NHSA
G.D.Searle LLC	国药准字J20140072	0.2g	Category B (乙)	XM01AHS002E001010378724	NHSA
大桐制药(中国)有限责任公司	国药准字H20255451	0.2g	Category B (乙)	XM01AHS002E001010380685	NHSA
以岭万洲国际制药有限公司	国药准字H20233445	0.1g	Category B (乙)	XM01AHS002E001010381048	NHSA
湖南九典诺纳医药科技有限公司	国药准字H20243276	0.2g	Category B (乙)	XM01AHS002E001010384319	NHSA
北京福元医药股份有限公司	国药准字H20213033	0.2g	Category B (乙)	XM01AHS002E001010400177	NHSA
中山可可康制药有限公司	国药准字H20243287	0.2g	Category B (乙)	XM01AHS002E001010400361	NHSA
江苏正大清江制药有限公司	国药准字H20193414	0.2g	Category B (乙)	XM01AHS002E001010401522	NHSA
福建海西新药创制股份有限公司	国药准字H20213779	0.2g	Category B (乙)	XM01AHS002E001010401554	NHSA
四川依科制药有限公司	国药准字H20264321	0.2g	Category B (乙)	XM01AHS002E001010402251	NHSA
四川新斯顿制药股份有限公司	国药准字H20233911	0.2g	Category B (乙)	XM01AHS002E001010402273	NHSA
四川梓橦宫药业股份有限公司	国药准字H20233449	0.2g	Category B (乙)	XM01AHS002E001010402300	NHSA
青岛百洋制药有限公司	国药准字H20203324	0.1g	Category B (乙)	XM01AHS002E001010404023	NHSA
浙江亚太药业股份有限公司	国药准字H20223814	0.2g	Category B (乙)	XM01AHS002E001010404744	NHSA
福州闽海药业有限公司	国药准字H20234697	0.2g	Category B (乙)	XM01AHS002E001010404833	NHSA
北大医药股份有限公司	国药准字H20213717	0.2g	Category B (乙)	XM01AHS002E001010409586	NHSA
G.D.Searle LLC	国药准字J20140072	0.2g	Category B (乙)	XM01AHS002E001010478724	NHSA
以岭万洲国际制药有限公司	国药准字H20233445	0.1g	Category B (乙)	XM01AHS002E001010481048	NHSA
湖南九典诺纳医药科技有限公司	国药准字H20243276	0.2g	Category B (乙)	XM01AHS002E001010484319	NHSA
中山可可康制药有限公司	国药准字H20243287	0.2g	Category B (乙)	XM01AHS002E001010500361	NHSA
江苏正大清江制药有限公司	国药准字H20193414	0.2g	Category B (乙)	XM01AHS002E001010501522	NHSA
四川新斯顿制药股份有限公司	国药准字H20233911	0.2g	Category B (乙)	XM01AHS002E001010502273	NHSA
四川梓橦宫药业股份有限公司	国药准字H20233449	0.2g	Category B (乙)	XM01AHS002E001010502300	NHSA
浙江亚太药业股份有限公司	国药准字H20223814	0.2g	Category B (乙)	XM01AHS002E001010504744	NHSA
福州闽海药业有限公司	国药准字H20234697	0.2g	Category B (乙)	XM01AHS002E001010504833	NHSA
北大医药股份有限公司	国药准字H20213717	0.2g	Category B (乙)	XM01AHS002E001010509586	NHSA
湖南九典诺纳医药科技有限公司	国药准字H20243276	0.2g	Category B (乙)	XM01AHS002E001010584319	NHSA
四川新斯顿制药股份有限公司	国药准字H20233911	0.2g	Category B (乙)	XM01AHS002E001010602273	NHSA
四川梓橦宫药业股份有限公司	国药准字H20233449	0.2g	Category B (乙)	XM01AHS002E001010602300	NHSA
浙江亚太药业股份有限公司	国药准字H20223814	0.2g	Category B (乙)	XM01AHS002E001010604744	NHSA
福州闽海药业有限公司	国药准字H20234697	0.2g	Category B (乙)	XM01AHS002E001010604833	NHSA
Upjohn US 2 LLC	国药准字HJ20140106	0.2g	Category B (乙)	XM01AHS002E001010678724	NHSA
湖南九典诺纳医药科技有限公司	国药准字H20243276	0.2g	Category B (乙)	XM01AHS002E001010684319	NHSA
中山可可康制药有限公司	国药准字H20243287	0.2g	Category B (乙)	XM01AHS002E001010700361	NHSA
四川新斯顿制药股份有限公司	国药准字H20233911	0.2g	Category B (乙)	XM01AHS002E001010702273	NHSA
四川梓橦宫药业股份有限公司	国药准字H20233449	0.2g	Category B (乙)	XM01AHS002E001010702300	NHSA
浙江亚太药业股份有限公司	国药准字H20223814	0.2g	Category B (乙)	XM01AHS002E001010704744	NHSA
福州闽海药业有限公司	国药准字H20234697	0.2g	Category B (乙)	XM01AHS002E001010704833	NHSA
Upjohn US 2 LLC	国药准字HJ20140106	0.2g	Category B (乙)	XM01AHS002E001010778724	NHSA
湖南九典诺纳医药科技有限公司	国药准字H20243276	0.2g	Category B (乙)	XM01AHS002E001010784319	NHSA
中山可可康制药有限公司	国药准字H20243287	0.2g	Category B (乙)	XM01AHS002E001010800361	NHSA
四川新斯顿制药股份有限公司	国药准字H20233911	0.2g	Category B (乙)	XM01AHS002E001010802273	NHSA
浙江亚太药业股份有限公司	国药准字H20223814	0.2g	Category B (乙)	XM01AHS002E001010804744	NHSA
福州闽海药业有限公司	国药准字H20234697	0.2g	Category B (乙)	XM01AHS002E001010804833	NHSA
Upjohn US 2 LLC	国药准字HJ20140106	0.2g	Category B (乙)	XM01AHS002E001010878724	NHSA
湖南九典诺纳医药科技有限公司	国药准字H20243276	0.2g	Category B (乙)	XM01AHS002E001010884319	NHSA
中山可可康制药有限公司	国药准字H20243287	0.2g	Category B (乙)	XM01AHS002E001010900361	NHSA
四川新斯顿制药股份有限公司	国药准字H20233911	0.2g	Category B (乙)	XM01AHS002E001010902273	NHSA
浙江亚太药业股份有限公司	国药准字H20223814	0.2g	Category B (乙)	XM01AHS002E001010904744	NHSA
福州闽海药业有限公司	国药准字H20234697	0.2g	Category B (乙)	XM01AHS002E001010904833	NHSA
Upjohn US 2 LLC	国药准字HJ20140106	0.2g	Category B (乙)	XM01AHS002E001010978724	NHSA
湖南九典诺纳医药科技有限公司	国药准字H20243276	0.2g	Category B (乙)	XM01AHS002E001010984319	NHSA
四川新斯顿制药股份有限公司	国药准字H20233911	0.2g	Category B (乙)	XM01AHS002E001011002273	NHSA
浙江亚太药业股份有限公司	国药准字H20223814	0.2g	Category B (乙)	XM01AHS002E001011004744	NHSA
福州闽海药业有限公司	国药准字H20234697	0.2g	Category B (乙)	XM01AHS002E001011004833	NHSA
湖南九典诺纳医药科技有限公司	国药准字H20243276	0.2g	Category B (乙)	XM01AHS002E001011084319	NHSA
四川新斯顿制药股份有限公司	国药准字H20233911	0.2g	Category B (乙)	XM01AHS002E001011102273	NHSA
浙江亚太药业股份有限公司	国药准字H20223814	0.2g	Category B (乙)	XM01AHS002E001011104744	NHSA
福州闽海药业有限公司	国药准字H20234697	0.2g	Category B (乙)	XM01AHS002E001011104833	NHSA
湖南九典诺纳医药科技有限公司	国药准字H20243276	0.2g	Category B (乙)	XM01AHS002E001011184319	NHSA
四川新斯顿制药股份有限公司	国药准字H20233911	0.2g	Category B (乙)	XM01AHS002E001011202273	NHSA
浙江亚太药业股份有限公司	国药准字H20223814	0.2g	Category B (乙)	XM01AHS002E001011204744	NHSA
福州闽海药业有限公司	国药准字H20234697	0.2g	Category B (乙)	XM01AHS002E001011204833	NHSA
湖南九典诺纳医药科技有限公司	国药准字H20243276	0.2g	Category B (乙)	XM01AHS002E001011284319	NHSA
四川新斯顿制药股份有限公司	国药准字H20233911	0.2g	Category B (乙)	XM01AHS002E001011302273	NHSA
浙江亚太药业股份有限公司	国药准字H20223814	0.2g	Category B (乙)	XM01AHS002E001011304744	NHSA
福州闽海药业有限公司	国药准字H20234697	0.2g	Category B (乙)	XM01AHS002E001011304833	NHSA
湖南九典诺纳医药科技有限公司	国药准字H20243276	0.2g	Category B (乙)	XM01AHS002E001011384319	NHSA
四川新斯顿制药股份有限公司	国药准字H20233911	0.2g	Category B (乙)	XM01AHS002E001011402273	NHSA
浙江亚太药业股份有限公司	国药准字H20223814	0.2g	Category B (乙)	XM01AHS002E001011404744	NHSA
福州闽海药业有限公司	国药准字H20234697	0.2g	Category B (乙)	XM01AHS002E001011404833	NHSA
四川新斯顿制药股份有限公司	国药准字H20233911	0.2g	Category B (乙)	XM01AHS002E001011502273	NHSA
福州闽海药业有限公司	国药准字H20234697	0.2g	Category B (乙)	XM01AHS002E001011504833	NHSA
四川新斯顿制药股份有限公司	国药准字H20233911	0.2g	Category B (乙)	XM01AHS002E001011602273	NHSA
福州闽海药业有限公司	国药准字H20234697	0.2g	Category B (乙)	XM01AHS002E001011604833	NHSA
四川新斯顿制药股份有限公司	国药准字H20233911	0.2g	Category B (乙)	XM01AHS002E001011702273	NHSA
福州闽海药业有限公司	国药准字H20234697	0.2g	Category B (乙)	XM01AHS002E001011704833	NHSA
四川新斯顿制药股份有限公司	国药准字H20233911	0.2g	Category B (乙)	XM01AHS002E001011802273	NHSA
福州闽海药业有限公司	国药准字H20234697	0.2g	Category B (乙)	XM01AHS002E001011804833	NHSA
四川新斯顿制药股份有限公司	国药准字H20233911	0.2g	Category B (乙)	XM01AHS002E001011902273	NHSA
石药集团欧意药业有限公司	国药准字H20203297	0.2g	Category B (乙)	XM01AHS002E001020102770	NHSA
青岛百洋制药有限公司	国药准字H20203325	0.2g	Category B (乙)	XM01AHS002E001020104023	NHSA
齐鲁制药(海南)有限公司	国药准字H20203490	0.2g	Category B (乙)	XM01AHS002E001020105847	NHSA
先声药业有限公司	国药准字H20213058	0.2g	Category B (乙)	XM01AHS002E001020105849	NHSA
北京亚宝生物药业有限公司	国药准字H20223019	0.2g	Category B (乙)	XM01AHS002E001020109542	NHSA
四川国为制药有限公司	国药准字H20203357	0.2g	Category B (乙)	XM01AHS002E001020180937	NHSA
以岭万洲国际制药有限公司	国药准字H20233446	0.2g	Category B (乙)	XM01AHS002E001020181048	NHSA
石药集团欧意药业有限公司	国药准字H20203297	0.2g	Category B (乙)	XM01AHS002E001020202770	NHSA
青岛百洋制药有限公司	国药准字H20203325	0.2g	Category B (乙)	XM01AHS002E001020204023	NHSA
齐鲁制药(海南)有限公司	国药准字H20203490	0.2g	Category B (乙)	XM01AHS002E001020205847	NHSA
北京亚宝生物药业有限公司	国药准字H20223019	0.2g	Category B (乙)	XM01AHS002E001020209542	NHSA
四川国为制药有限公司	国药准字H20203357	0.2g	Category B (乙)	XM01AHS002E001020280937	NHSA
以岭万洲国际制药有限公司	国药准字H20233446	0.2g	Category B (乙)	XM01AHS002E001020281048	NHSA
石药集团欧意药业有限公司	国药准字H20203297	0.2g	Category B (乙)	XM01AHS002E001020302770	NHSA
青岛百洋制药有限公司	国药准字H20203325	0.2g	Category B (乙)	XM01AHS002E001020304023	NHSA
四川国为制药有限公司	国药准字H20203357	0.2g	Category B (乙)	XM01AHS002E001020380937	NHSA
以岭万洲国际制药有限公司	国药准字H20233446	0.2g	Category B (乙)	XM01AHS002E001020381048	NHSA
石药集团欧意药业有限公司	国药准字H20203297	0.2g	Category B (乙)	XM01AHS002E001020402770	NHSA
青岛百洋制药有限公司	国药准字H20203325	0.2g	Category B (乙)	XM01AHS002E001020404023	NHSA
齐鲁制药(海南)有限公司	国药准字H20203490	0.2g	Category B (乙)	XM01AHS002E001020405847	NHSA
四川国为制药有限公司	国药准字H20203357	0.2g	Category B (乙)	XM01AHS002E001020480937	NHSA
以岭万洲国际制药有限公司	国药准字H20233446	0.2g	Category B (乙)	XM01AHS002E001020481048	NHSA
齐鲁制药(海南)有限公司	国药准字H20203490	0.2g	Category B (乙)	XM01AHS002E001020505847	NHSA
四川国为制药有限公司	国药准字H20203357	0.2g	Category B (乙)	XM01AHS002E001020580937	NHSA
四川国为制药有限公司	国药准字H20203357	0.2g	Category B (乙)	XM01AHS002E001020680937	NHSA
四川国为制药有限公司	国药准字H20203357	0.2g	Category B (乙)	XM01AHS002E001020780937	NHSA
四川国为制药有限公司	国药准字H20203357	0.2g	Category B (乙)	XM01AHS002E001020880937	NHSA
四川国为制药有限公司	国药准字H20203357	0.2g	Category B (乙)	XM01AHS002E001020980937	NHSA
四川依科制药有限公司	国药准字H20264321	0.2g	Category B (乙)	XM01AHS002E001010502251	NHSA
四川依科制药有限公司	国药准字H20264321	0.2g	Category B (乙)	XM01AHS002E001010602251	NHSA

Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.

Current under-review applications

Loaded records: 5 filings and 4 distinct first applicants.

Generic 4 · Supplement 1

Current under-review applications
Company / applicant	Acceptance number	Application type	Accepted	Strength / specification	View source
迪沙药业集团有限公司	CYHS2600766	Generic	2026/04/02	Not stated by source	CDE
陕西西岳制药有限公司	CYHS2601941	Generic	2026/08/10	Not stated by source	CDE
四川国为制药有限公司	CYHB2601446	Supplement	2026/07/28	Not stated by source	CDE
吉林亚泰永安堂药业有限公司	CYHS2502959	Generic	2025/08/13	Not stated by source	CDE
吉林亚泰永安堂药业有限公司	CYHS2502958	Generic	2025/08/13	Not stated by source	CDE

New generic filings in 2026

Loaded records: 2 filings and 2 distinct first applicants.

New generic filings in 2026
Company / applicant	Acceptance number	Application type	Accepted	Strength / specification	View source
迪沙药业集团有限公司	CYHS2600766	Generic	2026/04/02	Not stated by source	CDE
陕西西岳制药有限公司	CYHS2601941	Generic	2026/08/10	Not stated by source	CDE

API registrations

Non-component matches: 38 companies with A status and 14 I-status records. Component matches are listed separately and excluded from these counts.

Name	Company / applicant	Registration number	Status	Name match	Source update date	View source
塞来昔布	陕西西岳制药（扶风）有限公司	Y20260000229	I	Exact ingredient	2026/04/09	CDE
塞来昔布	上海锦帝九州药业（安阳）有限公司	Y20240001315	A	Exact ingredient	2026/06/17	CDE
塞来昔布	江西同和药业股份有限公司	Y20240001113	A	Exact ingredient	2026/05/28	CDE
塞来昔布	山东鲁抗医药股份有限公司	Y20230001246	A	Exact ingredient	2025/04/30	CDE
塞来昔布	安徽悦康凯悦制药有限公司	Y20230000906	A	Exact ingredient	2025/07/04	CDE
塞来昔布	千辉药业（安徽）有限责任公司	Y20230000649	A	Exact ingredient	2024/12/30	CDE
塞来昔布	昆明源瑞制药有限公司	Y20230000320	A	Exact ingredient	2024/09/25	CDE
塞来昔布	山东道合药业有限公司	Y20230000076	A	Exact ingredient	2024/06/28	CDE
塞来昔布	湖北省宏源药业科技股份有限公司	Y20210000794	A	Exact ingredient	2024/02/08	CDE
塞来昔布	湖南九典宏阳制药有限公司	Y20210000947	A	Exact ingredient	2024/02/02	CDE
塞来昔布	Upjohn US 2 LLC	Y20200001454	A	Exact ingredient	2026/04/11	CDE
塞来昔布	南通常佑药业科技有限公司	Y20210000043	A	Exact ingredient	2023/09/27	CDE
塞来昔布	Aurore Pharmaceuticals Private Limited	Y20200001196	I	Exact ingredient	2022/11/11	CDE
塞来昔布	河南东泰制药有限公司	Y20200000335	A	Exact ingredient	2025/08/09	CDE
塞来昔布	浙江海昇药业股份有限公司	Y20190000593	I	Exact ingredient	2023/08/11	CDE
塞来昔布	Kekule Pharma Limited	Y20190001045	I	Exact ingredient	2020/03/24	CDE
塞来昔布	CIPLA LTD.	Y20190021376	I	Exact ingredient	2020/01/10	CDE
塞来昔布	四川科伦药业股份有限公司	Y20190021398	A	Exact ingredient	2026/03/21	CDE
塞来昔布	扬子江药业集团江苏海慈生物药业有限公司	Y20190021195	A	Exact ingredient	2026/05/22	CDE
塞来昔布	江苏正大清江制药有限公司	Y20190009882	A	Exact ingredient	—	CDE
塞来昔布	Upjohn US 2 LLC	Y20190009148	A	Exact ingredient	2024/10/29	CDE
塞来昔布	江苏恒瑞医药股份有限公司	Y20190007241	A	Exact ingredient	2023/06/07	CDE
塞来昔布	四川国为制药有限公司	Y20180001644	A	Exact ingredient	2025/05/07	CDE
塞来昔布	天地恒一制药股份有限公司	Y20180001654	I	Exact ingredient	2019/03/13	CDE
塞来昔布	江苏润安制药有限公司	Y20180001195	A	Exact ingredient	2024/12/27	CDE
塞来昔布	山东朗诺制药有限公司	Y20180000610	A	Exact ingredient	2023/07/31	CDE
塞来昔布	瑞阳制药股份有限公司	Y20170002232	A	Exact ingredient	2026/02/14	CDE
塞来昔布	江西同和药业股份有限公司	Y20180000172	A	Exact ingredient	2025/07/04	CDE
塞来昔布	青岛国海生物制药有限公司	Y20170001448	I	Exact ingredient	—	CDE
塞来昔布	烟台万润药业有限公司	Y20170001331	I	Exact ingredient	—	CDE
塞来昔布	湖南方盛制药股份有限公司	Y20170001323	A	Exact ingredient	2024/07/02	CDE
塞来昔布	福建省福抗药业股份有限公司	Y20170001322	A	Exact ingredient	2025/07/28	CDE
塞来昔布	迪嘉药业集团股份有限公司	Y20170001274	A	Exact ingredient	2026/09/01	CDE
塞来昔布	苏州正济药业有限公司	Y20170001197	I	Exact ingredient	—	CDE
塞来昔布	河北仁合益康药业有限公司	Y20170001130	I	Exact ingredient	—	CDE
塞来昔布	艾美科健（中国）生物医药有限公司	Y20170001107	I	Exact ingredient	2025/01/04	CDE
塞来昔布	湖北美林药业有限公司	Y20170001098	A	Exact ingredient	2025/04/23	CDE
塞来昔布	艾美科健（中国）生物医药有限公司	Y20170001077	A	Exact ingredient	2024/01/16	CDE
塞来昔布	AARTI DRUGS LIMITED	Y20170001023	I	Exact ingredient	—	CDE
塞来昔布	Apitoria Pharma Private Limited	Y20170001012	A	Exact ingredient	2025/09/15	CDE
塞来昔布	深圳市海滨制药有限公司	Y20170000973	A	Exact ingredient	2024/06/06	CDE
塞来昔布	济宁神州医药有限公司	Y20170000869	A	Exact ingredient	2026/04/01	CDE
塞来昔布	山东诚汇双达药业有限公司	Y20170000787	A	Exact ingredient	2026/07/24	CDE
塞来昔布	南京亿华药业有限公司	Y20170000783	A	Exact ingredient	2024/10/01	CDE
塞来昔布	津药药业股份有限公司	Y20170000774	A	Exact ingredient	2024/11/26	CDE
塞来昔布	山东安信制药有限公司	Y20170000772	A	Exact ingredient	2026/10/29	CDE
塞来昔布	Macleods Pharmaceuticals Limited	Y20170000770	A	Exact ingredient	2024/01/17	CDE
塞来昔布	湖北华世通生物医药科技有限公司	Y20170000767	A	Exact ingredient	2024/02/08	CDE
塞来昔布	天津市中央药业有限公司	Y20170000723	A	Exact ingredient	2025/06/05	CDE
塞来昔布	Alembic Pharmaceuticals Limited	Y20170000568	A	Exact ingredient	2025/02/07	CDE
塞来昔布	池州东升药业有限公司	Y20170000496	I	Exact ingredient	—	CDE
塞来昔布	Hetero Drugs Limited, Unit-IX	Y20170000465	A	Exact ingredient	2024/11/26	CDE
塞来昔布	浙江海正药业股份有限公司	Y20170000353	A	Exact ingredient	2024/09/12	CDE
塞来昔布	Cadila Pharmaceuticals Limited	Y20170000300	I	Exact ingredient	—	CDE

A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.

What changed recently?

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.

Trial registration does not mean an application will follow.

This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.

NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.

No matching records were found in the currently loaded source data; coverage dates are listed below.

How current is each source?

CDE acceptances and review

Last successful update: 2026/11/10 07:27

Chemical-drug catalogue

Last successful update: 2026/11/10 07:23

Full API register

Last successful update: 2026/11/10 07:25

NHSA drug codes

Last successful update: 2026/11/05 06:45

The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.

NMPA drug delivery notices

Last successful update: 2026/11/10 18:31

First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.

Drug Clinical Trial Registry and Information Disclosure Platform

Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete

Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.

Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.

Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.

Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.

About the Chinese official sources

Each source counts a different type of public record. Coverage dates and gaps are listed separately above.

CDE — The Center for Drug Evaluation lists application acceptances and applications currently under review.
CDE catalogue — The chemical-drug catalogue lists approvals, marketing authorisation holders and the original inclusion categories.
NHSA — The National Healthcare Security Administration maintains medicine codes, companies and approval numbers; its database is not an application decision register.
NMPA — The National Medical Products Administration publishes delivery notices for approval documents and notifications. Loaded notices do not cover all historical approvals.
CDE API registry — The active pharmaceutical ingredient registry lists registrations and their A/I association-review status.
Drug Clinical Trial Registry — Public registration numbers, applicants, first-publication dates and original classifications/phases. States are dated site observations; revisions are not continuously tracked.

Official English name source: NMPA reference-product directory, Shaanxi MPA republication · 36-37

Free follow

Follow changes to Celecoxib Capsules

Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.

Subscriptions

Next-day facts and deliverable timelines

One email the next day when new facts are collected for your followed products.
Export the complete loaded event timeline for each followed product as CSV.
Add up to 4 additional recipients, each confirmed by email.
Increase your follow limit from 3 to 10 products.

Monthly

US$200

Billed every month

Quarterly

US$540

Billed every three months

US$180 per month

Yearly

US$1,920

Billed every year

US$160 per month

Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.

Separate one-time purchase

US Orange Book × China records comparison

Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.

Subscriptions and comparison-table access are purchased separately. Neither includes the other.

US$490

One payment · 12 months of access

Online comparison-table purchase is not enabled.

Billed by Creem, our merchant of record · Terms · Refund policy